Skip to content
Search

Latest Stories

Childhood obesity: Junk food ads to be banned from next year

Ban on junk food ads before 9pm watershed starts next year
gettyimages

Restrictions on junk food adverts are expected to prevent around 20,000 cases of childhood obesity

No Junk food ads on television will be allowed before the 9 pm watershed from October 2025 under a new law.

The UK government confirmed the final details of advertising restrictions, including a ban on paid online junk food adverts, on Tuesday (3 December).


The proposed legislation is part of a broader strategy to curb childhood obesity and address rising rates of obesity-related diseases such as diabetes and heart disease.

Detailed guidance on which food and drink categories will be covered by the regulations has also been published.

These measures are expected to remove 7.2 billion calories per year from UK children’s diets, potentially preventing around 20,000 cases of childhood obesity.

Health secretary Wes Streeting emphasised the need for such preventative action, stating: “Obesity robs our kids of the best possible start in life, sets them up for a lifetime of health problems, and costs the NHS billions.

“This government is taking action now to end the targeting of junk food ads at kids, across both TV and online.

“This is the first step to deliver a major shift in the focus of healthcare from sickness to prevention, and towards meeting our government’s ambition to give every child a healthy, happy start to life,” he added.

NHS data reveals that one in eight toddlers and primary school children are obese.

Professor Sir Stephen Powis, NHS national medical director, warned that rising childhood obesity could not only lead to health issues for young people later in life but also create problems for the future NHS, which is already spending over £11 billion to address the issue annually.

“We welcome this proposed legislation and look forward to working with the government and partners to help protect the good health of future generations,” he added.

Obesity is the second-largest preventable cause of cancer and is a major contributor to ill health that prevents people from participating fully in work.

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less